Clinical Trial Update: Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older [Phase 1]

View source ↗

Summary

Phase I clinical trial of PCV24 in adults aged 18 and older has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• PCV24 (24-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Shanghai Reinovax Biologics Co.,LTD | Conditions: Pneumococcal Infectious Disease | Phase 1 | Status: COMPLETED